Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
Sarcoidosis with Pulmonary Fibrosis
2000
Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study
2015
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Sarcoidosis
2007
Anti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plants
2009 Standout
Gout: On the brink of novel therapeutic options for an ancient disease
2004
Gout and hyperuricemia
2002
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Tobacco Smoking and Lung Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiological Evidence Among the Japanese Population
2006
Antigen-induced Proliferative Response of Lavage and Blood T Lymphocytes: Comparison of Cells from Normal Subjects and Patients with Sarcoidosis
1991
Late-Onset Sarcoidosis
2012
Pomegranate and its Many Functional Components as Related to Human Health: A Review
2010 Standout
Skin manifestations of sarcoidosis
2012
HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites
2003
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Marine natural products
1990 Standout
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
2011 Standout
Imaging in Sarcoidosis
2007
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
A New Tool To Assess Sarcoidosis Severity
2006
Uric Acid and Cardiovascular Risk
2008 Standout
Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature
2001 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Gout
2009 Standout
Uric Acid: The Oxidant-Antioxidant Paradox
2008
TFOS DEWS II pathophysiology report
2017 Standout
Sarcoidosis of the Heart
1993
Prognosticators for Visual Outcome in Sarcoid Uveitis
1996
Risk Factors for Development of Decreased Kidney Function in a Southeast Asian Population
2005
Sarcoidosis
2013 Standout
Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic Correlation
2010
Sarcoidosis
2003
Risk factors for ocular sarcoidosis
1989
Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
2011 Standout
Long-term Outcome of Pediatric Sarcoidosis with Emphasis on Pulmonary Status
1992
Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis
2005
Gout
2003
Interstitial lung disease guideline
2008
Elevated Uric Acid Increases the Risk for Kidney Disease
2008
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Stage IV sarcoidosis: comparison of survival with the general population and causes of death
2011
A unifying pathway for essential hypertension
2005
Gout
2016 Standout
The Use of Low Dose Methotrexate in Refractory Sarcoidosis
1990
Vogt-Koyanagi-Harada syndrome
1995
Ocular sarcoidosis
2012
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Sarcoidosis
1997 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Effects of chloroquine on viral infections: an old drug against today's diseases
2003 Standout
Cytokine Profile in Aqueous Humor and Sera of Patients with Infectious or Noninfectious Uveitis
2006
Pomegranate as a cosmeceutical source: Pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells
2005
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Essential Hypertension, Progressive Renal Disease, and Uric Acid
2005
The Clinical Management of Sarcoidosis A 50-Year Experience at the Johns Hopkins Hospital
1999
Cerebrospinal Fluid Immunoglobulin Abnormalities in Neurosarcoidosis
1989
Transbronchial Lung Biopsy in the Diagnosis of Suspected Ocular Sarcoidosis
1993
Sarcoidosis
2007 Standout
HLA and Sarcoidosis in the Japanese
1989
Central nervous system sarcoidosisdiagnosis and management
1999 Standout
Global epidemiology of gout: prevalence, incidence and risk factors
2015 Standout
Randomized Trial of Prolonged Chloroquine Therapy in Advanced Pulmonary Sarcoidosis
1999
Sarcoidosis Blood Transcriptome Reflects Lung Inflammation and Overlaps with Tuberculosis
2011
Renierol from marine sponge Haliclona.SP.: A natural inhibitor of xanthine oxidase with hypouricemic effects
2008
Epidemiology of sarcoidosis in the Isle of Man--1: A case controlled study.
1987
Treatment of sarcoid meningitis with radiotherapy
1982
Neurologic Manifestations in Sarcoidosis
1977
Neurosarcoidosis: clinical presentations and course in 50 patients
2009
The Tumor Lysis Syndrome
2011 Standout
Causes and frequency of blindness in patients with intraocular inflammatory disease.
1996 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Serum-migration inhibitory activity in patients with sarcoidosis
1979 StandoutNobel
The Immune Response in Tuberculosis
2013 Standout
MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy.
1994
An Electron Microscopic Study of Central Nervous System Sarcoidosis
1981
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Sarcoidosis of the Lacrimal Sac
1981
Sarcoidosis and Its Neurological Manifestations
1985
The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.
2003
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
2004
T-Cell Suppression by Programmed Cell Death 1 Ligand 1 on Retinal Pigment Epithelium during Inflammatory Conditions
2009 StandoutNobel
Primary Acquired Nasolacrimal Duct Obstruction
1986 Standout
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
1986 StandoutScience
Leukotactic Dysfunction in Sarcoidosis
1976
Sarcoidosis in Causians, Blacks and Asians in London
1985
Works of M. Odaka being referenced
Does hyperuricemia aeffect mortality? A prospective cohort study of Japanese male workers.
2000
A COOPERATIVE STUDY OF SARCOIDOSIS IN ASIA AND AFRICA: ANALYTIC EPIDEMIOLOGY*
1976
[Cigarette smoking and mortality among Japanese males in a prospective cohort study].
1991
Course and prognosis of sarcoidosis around the world
1974